Bülent Kantarçeken

Suggest Changes
Learn More
BACKGROUND/AIMS Pegylated alfa interferon is the only immunomodulatory drug licensed for hepatitis B. We evaluated the safety and tolerability of peginterferon alfa-2a (40KD) in patients with chronic(More)